Market Tracker

09/30 5:16pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

54.01
Delayed Data
As of 3:59pm ET
 +0.72 / +1.35%
Today’s Change
26.02
Today|||52-Week Range
57.23
+20.34%
Year-to-Date
3 Biotechs That Could Be M&A Targets
Sep 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close53.29
Today’s open53.47
Day’s range52.13 - 54.27
Volume786,242
Average volume (3 months)784,630
Market cap$7.5B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-7.77%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book10.85

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.53-1.24%
MNKMallinckrodt Plc+0.79+1.15%
RDYDr.Reddy's Laborator...+0.18+0.39%
ALKSAlkermes Plc+0.32+0.69%
Data as of 4:04pm ET, 09/30/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts